• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about CMPS

Recent news which mentions CMPS

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
July 28, 2023
Tickers ATAI CMPS DMTTF DRUG
Tags Legal Penny Stocks Small Cap
From Benzinga
This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock
July 28, 2023
Tickers CMPS
Tags Recent Press Releases Market News CMPS
From Motley Fool
Compass' Psilocybin Therapy Proves Helpful In Treating Anorexia: Clinical Trial Shows
July 25, 2023
Tickers CMPS
Tags CMPS Psychedelics General
From Benzinga
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
July 24, 2023
Tickers CLABF CMPS ENVB FLHLF
Tags ENVB Psychedelics Reform Benzinga
From Benzinga
AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies
July 24, 2023
Tickers CMPS
Tags Markets COMPASS Pathways PLC Partner Content
From Benzinga
Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD
July 21, 2023
Tickers ASML CMPS DHR ETN
Tags Benzinga Market News ASML
From Benzinga
Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies'
July 18, 2023
Tickers CMPS
Tags Markets Psilocybin program Cannabis
From Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Tickers ABCL ADIL ARDS ARTW
Tags SOPA NSPR BANL
From Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
July 11, 2023
Tickers AWKNF CMPS DMTTF FLHLF
Tags CMPS Psychedelics AWKNF
From Benzinga
Top 5 Health Care Stocks That May Collapse This Quarter
July 10, 2023
Tickers CAH CDNA CMPS NERV
Tags Small Cap Penny Stocks CDNA
From Benzinga
Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 07, 2023
Tickers AAOI ALPS ASLN AUID
Tags Intraday Update Movers GREE
From Benzinga
COMPASS Pathways Projects 2027 Commercialization Timeline For Psilocybin Therapy
July 07, 2023
Tickers CMPS
Tags CMPS Psychedelics Small Cap
From Benzinga
Alibaba, Kura Sushi USA And Other Big Stocks Moving Higher On Friday
July 07, 2023
Tickers BABA CCO CDNA CIFR
Tags big gainers CCO Benzinga
From Benzinga
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
July 06, 2023
Tickers CMPS
Tags MAPS PBC Small Cap Psychedelics
From Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers ATAI CMPS HTGC
Tags News CMPS Psychedelics
From Benzinga
Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?
July 01, 2023
Tickers CMPS
Tags Recent Press Releases CMPS Market News
From Motley Fool
The 3 Best Psychedelic Stocks to Buy Now
June 29, 2023
Tickers CMPS GHRS MNMD
Tags Stocks to Buy NASDAQ:CMPS,NASDAQ:MNMD,NASDAQ:GHRS MNMD
From InvestorPlace
TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
June 21, 2023
Tickers ATAI CMPS CYBN MNMD
Tags CMPS CYBN ATAI
From MarketWatch
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers CMPS MNMD NUMIF
Tags Cedar Clinical Research Contracts Markets
From Benzinga
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Tickers CMPS CYBN DMTTF ENVB
Tags DMTTF MNMD News
From Benzinga
Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD
May 30, 2023
Tickers CMPS NUMIF
Tags treatment/resistant depression Cannabis Benzinga
From Benzinga
Trial Gives Cancer Patients 18 Months Of Robust Benefits After One Psilocybin Session
May 26, 2023
Tickers CMPS
Tags Market News Benzinga Psychedelics
From Benzinga
Compass shares jump as study shows psychedelic-based drug improved depression in cancer patients
May 26, 2023
Tickers CMPS SPX
Tags UK:CPG CMPS SPX
From MarketWatch
Link Between Cancer And Psilocybin: Research On This Palliative Promise
May 22, 2023
Tickers CMPS
Tags Market News Psychedelic/Assisted Therapies Benzinga
From Benzinga
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
Tickers ATAI CMND CMPS CYBN
Tags NUGL IGXT Legal
From Benzinga
Expert Ratings for Compass Pathways
May 11, 2023
Tickers CMPS
Tags Analyst Ratings BZI/AAR CMPS
From Benzinga
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
May 11, 2023
Tickers CMPS
Tags Psychedelics CMPS American Medical Association
From Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
Tickers ATAI CMPS
Tags Penny Stocks Small Cap Psychedelics
From Benzinga
Compass Pathways Plc (CMPS) Q1 2023 Earnings Call Transcript
May 11, 2023
Tickers CMPS
Tags CMPS Market News Recent Press Releases
From Motley Fool
Compass Pathways: Q1 Earnings Insights
May 11, 2023
Tickers CMPS
Tags CMPS Benzinga BZI/Recaps
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap